Latest Stanford, Intermountain Grant Recipients Announced
Stanford Medicine and Intermountain Healthcare announced the recipients of five new seed grants to conduct collaborative research to improve health care. These one-year seed grants of up to $75,000 are awarded to projects jointly led by principal investigators from Stanford and Intermountain. The grants took effect Sept. 1.
In 2016, the two organizations began collaborating on joint clinical, research and education projects. The Intermountain-Stanford Collaboration grant is designed for project teams with paired Principal Investigators, one each from Stanford University’s School of Medicine and Intermountain Healthcare. Eligible categories include performance improvement, innovation and education, with a focus on health care transformation.
2017 Grant Recipients
Following are the names of the grant recipients and the project titles:
Alex Sox-Harris, PhD, associate professor of research at Stanford, and Stephen Warner, MD, Intermountain — Setting a foundation for collaborative surgical health services research at Stanford Health Care, Intermountain Healthcare and the Veterans Health Administration.
Ian Brown, MD, clinical assistant professor of emergency medicine at Stanford, and Joseph Bledsoe, MD, Intermountain — Electronic decision support for the diagnosis and treatment of acute pulmonary embolism in the emergency department.
Alan Schroeder, MD, clinical associate professor of pediatrics at Stanford, and Eric Coon, MD, Intermountain — Optimizing value in bronchiolitis: The bronchiolitis follow-up intervention trial.
Purvesh Khatri, PhD, assistant professor of medicine and of biomedical data science at Stanford, and Patrick Carroll, MD, Intermountain — Early detection of neonatal early onset sepsis using the Sepsis MetaScore: A genomic analysis of cord blood.
Marcy Winget, PhD, clinical associate professor of medicine at Stanford, and Brenda Reiss-Brennan, PhD, Intermountain — Pragmatic design for enhanced team-based primary care.
Aruna Subramanian, MD, clinical associate professor of medicine at Stanford, and Brandon Webb, MD, Intermountain — Repurposing an old drug for a new epidemic: Ursodeoxycholic acid and C. difficile infection.